Department of Dentistry, Ulsan University Hospital, University of Ulsan College of Medicine, 25, Daehakbyeongwon-ro, Dong-gu, Ulsan 44033, Republic of Korea.
Department of Oral and Maxillofacial Surgery, Ulsan University Hospital, University of Ulsan College of Medicine, 25, Daehakbyeongwon-ro, Dong-gu, Ulsan 44033, Republic of Korea.
Medicina (Kaunas). 2024 Sep 16;60(9):1509. doi: 10.3390/medicina60091509.
: With increases in cancer incidence and the number of cancer survivors, the demand for cancer management is growing. However, studies on dental prosthetic treatment for patients with cancer are rare. We aim to investigate the dental prosthetic treatment in patients with cancer aged ≥65 years after expanded health insurance coverage. : This retrospective study included patients who were treated with implants and removable dentures at Ulsan University Hospital in South Korea between June 2015 and June 2023. Data on age, sex, cancer location, comorbid systemic diseases, number of remaining teeth, dental prosthetic treatment history, type of dental prosthetic treatment, and insurance coverage status were extracted from patient medical records and panoramic radiographs. The influence of multiple variables on dental prosthetic treatment was analyzed using the Chi-square and Fisher's exact tests. : The study included 61 patients with cancer (32 men, 29 women; average age: 70.9 years). Among them, 56 (91.8%) had insurance coverage benefits, and 34 (55.7%) received treatments such as implants, removable partial dentures, or complete dentures for the first time. Treatment types included 37 (60.7%) cases of implant prostheses and 24 (39.3%) conventional removable dentures. No statistical differences were observed in the type of dental prosthetic treatment according to sex, age, cancer location, number of systemic diseases, and dental prosthetic treatment history ( > 0.05). Patients with <10 remaining teeth received treatment with conventional removable dentures, which was statistically significant ( < 0.001). : Of the 61 patients, 56 (91.8%) received insurance benefits, and 34 (55.7%) underwent dental prosthetic treatment for the first time. Within the limitations of this retrospective study, the expanded health insurance coverage alleviated the unmet demand for dental prosthetic treatment. As cancer prevalence continues to increase, expanding customized health insurance coverage is crucial to meet this demand.
随着癌症发病率和癌症幸存者人数的增加，对癌症管理的需求不断增长。然而，针对癌症患者的牙科修复治疗的研究很少。我们旨在研究扩大健康保险覆盖范围后≥65 岁癌症患者的牙科修复治疗。
这项回顾性研究纳入了 2015 年 6 月至 2023 年 6 月在韩国蔚山大学医院接受种植体和可摘义齿治疗的患者。从患者病历和全景片提取年龄、性别、癌症部位、合并系统疾病、余留牙数、牙科修复治疗史、牙科修复治疗类型和保险覆盖状态等数据。使用卡方检验和 Fisher 确切检验分析多个变量对牙科修复治疗的影响。
该研究纳入了 61 例癌症患者（32 例男性，29 例女性；平均年龄：70.9 岁）。其中 56 例（91.8%）有保险覆盖受益，34 例（55.7%）首次接受种植体、可摘局部义齿或全口义齿治疗。治疗类型包括 37 例（60.7%）种植体义齿和 24 例（39.3%）常规可摘义齿。性别、年龄、癌症部位、系统疾病数量和牙科修复治疗史对治疗类型无统计学差异（>0.05）。余留牙数<10 颗的患者接受常规可摘义齿治疗，差异有统计学意义（<0.001）。
在 61 例患者中，56 例（91.8%）获得了保险受益，34 例（55.7%）首次接受了牙科修复治疗。在这项回顾性研究的限制内，扩大健康保险覆盖范围缓解了牙科修复治疗的未满足需求。随着癌症发病率的持续增加，扩大定制健康保险覆盖范围对于满足这一需求至关重要。
